AACR Annual Meeting 2010 2010 Forum Session Titles
Washington, DC
2010 Forums
Circulating Tumor Cells: Finding Them and Understanding Them
Moderator: Daniel A. Haber, Massachusetts General Hospital, Charlestown, MA
Klaus Pantel, Univ. Medical Ctr. Hamburg-Eppendorf, Hamburg, Germany
Gerhardt Attard, Inst. of Cancer Research, Sutton, United Kingdom
Animal Models for Preclinical Evaluation of Drugs for Metastatic Disease: Are GEMs the Jewel in the Crown or an Expensive Luxury?
Moderator: Suzanne A. Eccles, McElwain Laboratories, Sutton, United Kingdom
Terry A. Van Dyke. NCI-Frederick, Frederick, MD
Ann Richmond. Vanderbilt-Ingram Cancer Ctr., Nashville, TN
Anti-TGFβ Signaling Therapy: Balancing the Pros and Cons
Moderator: Rosemary J. Akhurst, UCSF Helen Diller Family Comp. Cancer Ctr., San Francisco, CA
Steven M. Albelda, Abramson Cancer Ctr. of Univ. of Penn., Philadelphia, PA
Neil A. Bhowmick, Vanderbilt Univ., Nashville, TN
Antioxidants and Cancer Prevention: Molecular, Epidemiologic, and Public Perspectives
Moderator: Eric A. Klein, The Cleveland Clinic Lerner Research Inst., Cleveland, OH
Alan R. Kristal, Fred Hutchinson Cancer Research Ctr., Seattle, WA
Regina M. Santella, Columbia Univ. Mailman School of Public Health, New York, NY
Tara Parker-Pope, New York Times, New York, NY
Cellular Senescence: Molecular Basis and Relevance for Cancer
Moderator: Jiri Bartek, Danish Cancer Society, Copenhagen, Denmark
Fabrizio D'Adda di Fagagna, Ifom Foundation, Milano, Italy
Pier Paolo Pandolfi, Beth Israel Deaconess Medical Ctr., Boston, MA
Cancer Stem Cells: Somewhere, Everywhere, or Nowhere?
Moderator: Emmanuelle Passegué, UCSF Comprehensive Cancer Ctr., San Francisco, CA
Tessa L. Holyoake, University of Glasgow, Glasgow, United Kingdom
Jeffrey M. Rosen, Baylor College of Medicine, Houston, TX
The Role of Vitamin D in Cancer Prevention: What Do We Really Know?
Moderator: Virginia W. Hartmuller, The Scientific Consulting Group, Inc., Gaithersburg, MD
Rachael Z. Stolzenberg-Solomon, National Cancer Inst., Rockville, MD
Edward L. Giovannucci, Harvard School of Public Health, Boston, MA
Joanne E. Manson, Brigham & Women's Hospital, Boston, MA
Antiangiogenic Therapy-Induced Malignant Progression: Preclinical Anomaly or Clinical Reality
Moderator: Robert S. Kerbel, Univ. of Toronto Sunnybrook HSC, Toronto, ON, Canada
Gregory D. Plowman, Genentech, Inc., South San Francisco, CA
Donald M. McDonald, UCSF, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Oncology Drug Discovery in Academia: Key Strategies and Challenges
Moderator: Michael Morrissey, Exelixis, S. San Francisco, CA
James H. Doroshow, NCI-DCTD, Bethesda, MD
Neil W. Gibson, Pfizer, Inc., La Jolla, CA
Advancing Cancer Biomarkers to Cancer Diagnostics: Increasing the Pace of Progress
Moderator: Anna D. Barker, National Cancer Inst., Bethesda, MD
Joe W. Gray, Lawrence Berkeley National Laboratory, Berkeley, CA
Sanjiv Sam Gambhir, Stanford Univ., Stanford, CA
Laura J. Esserman, UCSF, Helen Diller Family Comprehensive Cancer Ctr., San Francisco, CA
Integrating Immunology with Cancer Biology and Medicine
Moderator: Glenn Dranoff, Dana-Farber Cancer Inst., Boston, MA
Charlotte E. Ariyan, Memorial Sloan-Kettering Cancer Center, New York, NY (replaced Wolf Hervé Fridman)
Daniel Hirschhorn-Cymerman, Memorial Sloan-Kettering Cancer Center, New York, NY (replaced Jedd D. Wolchok)
1